[Comparative effectiveness of rifampicin for parenteral administration and internal dose in the treatment of experimental plague in albino mice] - PubMed (original) (raw)
[Article in Russian]
- PMID: 8593093
Comparative Study
[Comparative effectiveness of rifampicin for parenteral administration and internal dose in the treatment of experimental plague in albino mice]
[Article in Russian]
L N Makarovskaia et al. Antibiot Khimioter. 1995 Jun.
Abstract
The therapeutic effects of parenteral and oral rifampicins were studied comparatively in a model of experimental plague of albino mice infected subcutaneously and by aerosol. The study showed that in a dose of 25 mg/kg rifampicin was highly efficient in the treatment of the albino mice with experimental glandular plague when the drug was administered either parenterally or orally for 7 days (100-percent survival). The parenteral rifampicin was advantageous when used in lower doses (6.25-12.5 mg/kg) or for a shorter period (3-5 days): 70-100-percent survival against not more than 30 per cent with the oral administration of the drug. It was especially evident when the animals were infected by aerosol. The results made it possible to recommend rifampicin injections in the treatment of the most severe forms of pneumonic plague.
Similar articles
- [Therapeutic effect of azlocillin and its combinations with other antibiotics in experimental plague infection].
Markovskaia EI, Makarovskaia LN, Ryzhkova VV, Zurabian VA. Markovskaia EI, et al. Antibiot Khimioter. 1993 Jul;38(7):37-9. Antibiot Khimioter. 1993. PMID: 8161276 Russian. - [Efficacy of rifampicin in experimental plague infection].
Makarovskaia LN, Shcherbaniuk AI, Bugaeva OK. Makarovskaia LN, et al. Antibiot Khimioter. 1993 Jul;38(7):34-6. Antibiot Khimioter. 1993. PMID: 8161275 Russian. - New World tegumentar leishmaniasis: chemotherapeutic activity of rifampicin in humans and experimental murine model.
Do Valle TZ, Oliveira Neto MP, Schubach A, Lagrange PH, Da Costa SC. Do Valle TZ, et al. Pathol Biol (Paris). 1995 Sep;43(7):618-21. Pathol Biol (Paris). 1995. PMID: 8570267 Review. - [Yersinia pestis and plague - an update].
Stock I. Stock I. Med Monatsschr Pharm. 2014 Dec;37(12):441-8; quiz 449. Med Monatsschr Pharm. 2014. PMID: 25643450 Review. German.
Cited by
- Antibiotic Therapy of Plague: A Review.
Sebbane F, Lemaître N. Sebbane F, et al. Biomolecules. 2021 May 12;11(5):724. doi: 10.3390/biom11050724. Biomolecules. 2021. PMID: 34065940 Free PMC article. Review. - Antibiotic treatment of experimental pneumonic plague in mice.
Byrne WR, Welkos SL, Pitt ML, Davis KJ, Brueckner RP, Ezzell JW, Nelson GO, Vaccaro JR, Battersby LC, Friedlander AM. Byrne WR, et al. Antimicrob Agents Chemother. 1998 Mar;42(3):675-81. doi: 10.1128/AAC.42.3.675. Antimicrob Agents Chemother. 1998. PMID: 9517950 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical